Daniel E Knutson

6PUBLICATIONS
21CO-AUTHORS
Biomolecular modelling and designToxicology (incl. clinical toxicology)Molecular medicineNeurology and neuromuscular diseasesGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 28, 2021
Overcoming the Low Oral Bioavailability of Deuterated Pyrazoloquinolinone Ligand DK-I-60-3 by Nanonization: A Knowledge-Based Approach.

Jelena R Mitrović, Branka Divović-Matović, Daniel E Knutson

|Feb 02, 2021
The α6 GABAA Receptor Positive Allosteric Modulator DK-I-56-1 Reduces Tic-Related Behaviors in Mouse Models of Tourette Syndrome.

Roberto Cadeddu, Daniel E Knutson, Laura J Mosher

|Aug 14, 2020
Imidazodiazepine Anticonvulsant, KRM-II-81, Produces Novel, Non-diazepam-like Antiseizure Effects.

Daniel E Knutson, Jodi L Smith, Xingjie Ping

|Feb 19, 2020
The Effects of pH on the Structure and Bioavailability of Imidazobenzodiazepine-3-Carboxylate MIDD0301.

M S Rashid Roni, Guanguan Li, Brandon N Mikulsky

|Mar 09, 2018
Cerebellar α6 -subunit-containing GABAA receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders.

Lih-Chu Chiou, Hsin-Jung Lee, Margot Ernst

|Feb 27, 2018
Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABAAR) α6 Subtype with Improved Metabolic Stability and Enhanced Bioavailability.

Daniel E Knutson, Revathi Kodali, Branka Divović

Pageof 1

Frequent Collaborators

6 joint publications

James M Cook

2 joint publications

Leggy A Arnold

2 joint publications

Lih-Chu Chiou

1 joint publications

Michael R Stephen